Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thuy T Luu

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Natural Products|April 3, 2015
Allotides: Proline-Rich Cystine Knot α-Amylase Inhibitors from Allamanda catharticaPhuong Q T Nguyen, Thuy T Luu, Yang Bai, et al.
The FEBS Journal|July 22, 2014
Discovery and characterization of pseudocyclic cystine-knot α-amylase inhibitors with high resistance to heat and proteolytic degradationPhuong Q T Nguyen, Shujing Wang, Akshita Kumar, et al.
Cancers|January 20, 2021
Soluble and Exosome-Bound α-Galactosylceramide Mediate Preferential Proliferation of Educated NK Cells with Increased Anti-Tumor CapacityArnika K Wagner, Ulf Gehrmann, Stefanie Hiltbrunner, et al.
Life Science Alliance|February 17, 2021
Short-term IL-15 priming leaves a long-lasting signalling imprint in mouse NK cells independently of a metabolic switchThuy T Luu, Laurent Schmied, Ngoc-Anh Nguyen, et al.
European Journal of Immunology|December 14, 2019
IL-15 and CD155 expression regulate LAT expression in murine DNAM1<sup>+</sup> NK cells, enhancing their effectors functionsThuy T Luu, Arnika K Wagner, Laurent Schmied, et al.
Frontiers in Immunology|June 27, 2022
FOXO1 and FOXO3 Cooperatively Regulate Innate Lymphoid Cell DevelopmentThuy T Luu, Jonas Nørskov Søndergaard, Lucía Peña-Pérez, et al.
Science Signaling|April 11, 2023
SHP-1 localization to the activating immune synapse promotes NK cell tolerance in MHC class I deficiencyLaurent Schmied, Thuy T Luu, Jonas N Søndergaard, et al.
Journal for Immunotherapy of Cancer|November 17, 2024
Inhibition of Cbl-b restores effector functions of human intratumoral NK cellsSofia Tundo, Marcel Trefny, Andrijana Rodić, et al.
Science Immunology|June 5, 2026
Cytotoxic CD39<sup>+</sup> tumor-associated NK cells respond to NKG2A blockade in lung cancerClara Serger, Lucas Rebuffet, Michael T Sandholzer, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Natural Products|April 3, 2015
Allotides: Proline-Rich Cystine Knot α-Amylase Inhibitors from Allamanda catharticaPhuong Q T Nguyen, Thuy T Luu, Yang Bai, et al.
The FEBS Journal|July 22, 2014
Discovery and characterization of pseudocyclic cystine-knot α-amylase inhibitors with high resistance to heat and proteolytic degradationPhuong Q T Nguyen, Shujing Wang, Akshita Kumar, et al.
Cancers|January 20, 2021
Soluble and Exosome-Bound α-Galactosylceramide Mediate Preferential Proliferation of Educated NK Cells with Increased Anti-Tumor CapacityArnika K Wagner, Ulf Gehrmann, Stefanie Hiltbrunner, et al.
Life Science Alliance|February 17, 2021
Short-term IL-15 priming leaves a long-lasting signalling imprint in mouse NK cells independently of a metabolic switchThuy T Luu, Laurent Schmied, Ngoc-Anh Nguyen, et al.
European Journal of Immunology|December 14, 2019
IL-15 and CD155 expression regulate LAT expression in murine DNAM1<sup>+</sup> NK cells, enhancing their effectors functionsThuy T Luu, Arnika K Wagner, Laurent Schmied, et al.
Frontiers in Immunology|June 27, 2022
FOXO1 and FOXO3 Cooperatively Regulate Innate Lymphoid Cell DevelopmentThuy T Luu, Jonas Nørskov Søndergaard, Lucía Peña-Pérez, et al.
Science Signaling|April 11, 2023
SHP-1 localization to the activating immune synapse promotes NK cell tolerance in MHC class I deficiencyLaurent Schmied, Thuy T Luu, Jonas N Søndergaard, et al.
Journal for Immunotherapy of Cancer|November 17, 2024
Inhibition of Cbl-b restores effector functions of human intratumoral NK cellsSofia Tundo, Marcel Trefny, Andrijana Rodić, et al.
Science Immunology|June 5, 2026
Cytotoxic CD39<sup>+</sup> tumor-associated NK cells respond to NKG2A blockade in lung cancerClara Serger, Lucas Rebuffet, Michael T Sandholzer, et al.
Pageof 1